home
Covid-Social-Media-1600x380

Physiatrist Resource Center


Members & Publications

In-Depth Resources for Physiatrists

We are supporting members by creating timely, needed resources, collaborating across health care and highlighting the best education and news that is applicable to you and your PM&R practice right now. As the primary medical specialty society for physical medicine and rehabilitation, this is your place for resources to help you today.


AAPM&R members: Even more resources are being shared between physiatrists in our Care in the Time of COVID-19 member forum on PhyzForum. Exchange important dialogue about your challenges, ask your questions and concerns as well as share resources with each other.

If you can't find what you need or would like additional support, we're here to help. Contact us at (847) 737-6000 or email covidresponse@aapmr.org.

Webinar Recordings

Members: 20+ COVID-19 specific webinar recordings are now available for you to access. Thank you to our panelists and participants!

View all COVID-19 Webinars.

From the AAPM&R Board of Governors

"Our country is in the midst of a medical pandemic. The AAPM&R (Academy), including its volunteer leaders and staff, have enormous empathy for our members, their patients, and families as COVID-19 has disrupted every aspect of our personal and professional lives. Together, we need to find the resilience to persevere for our personal and our patients’ health and well-being. Together, we need to find the resilience to persevere for our personal and our patients’ health and well-being.”  Read the full statement here.

Stay Up-to-Date

DEA Releases Temporary Rule Extending COVID-19 Telehealth Flexibilities

May 16, 2023, 09:51 AM by Christina Ghanayem

The Drug Enforcement Administration (DEA) has released a temporary rule extending COVID-19 telehealth flexibilities for the prescription of controlled substances. Per the rule, DEA states:

  • The full set of telemedicine flexibilities regarding prescription of controlled medications as were in place during the COVID-19 PHE will remain in place through November 11, 2023.
  • Additionally, for any practitioner-patient telemedicine relationships that have been or will be established on or before November 11, 2023, the full set of telemedicine flexibilities regarding prescription of controlled medications as were in place during the COVID-19 PHE will continue to be permitted via a one-year grace period through November 11, 2024. In other words, if a patient and a practitioner have established a telemedicine relationship on or before November 11, 2023, the same telemedicine flexibilities that have governed the relationship to that point are permitted until November 11, 2024.

A DEA press release for the rule is available here. Please contact healthpolicy@aapmr.org with any questions.